Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2023
Historique:
received: 09 01 2023
revised: 24 07 2023
accepted: 25 07 2023
medline: 18 9 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

In preclinical research, the use of [ A total of 29 PS2APP, 20 P301S and 12 wild-type mice aged 4.4 to 19.8 months received a dynamic [ [ [

Identifiants

pubmed: 37541098
pii: S2213-1582(23)00175-4
doi: 10.1016/j.nicl.2023.103484
pmc: PMC10407951
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103484

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Letizia Vogler (L)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Anna Ballweg (A)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Bernd Bohr (B)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Nils Briel (N)

Center for Neuropathology, LMU Munich, Munich, Germany.

Karin Wind (K)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Melissa Antons (M)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Lea H Kunze (LH)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Johannes Gnörich (J)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Simon Lindner (S)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Franz-Josef Gildehaus (FJ)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Karlheinz Baumann (K)

Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Guido Boening (G)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Sibylle I Ziegler (SI)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Johannes Levin (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Andreas Zwergal (A)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany; German Center for Vertigo and Balance Disorders (DSGZ), University Hospital of Munich, LMU Munich, Munich, Germany.

Günter U Höglinger (GU)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Jochen Herms (J)

Center for Neuropathology, LMU Munich, Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital of Munich, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Electronic address: matthias.brendel@med.uni-muenchen.de.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH